Symbols

ULBI

Ultralife·NASDAQ

--(--)

ULBI fundamentals

ULBI Q4 2025 Earnings

Ultralife (ULBI) released its earnings on Mar 10, 2026: revenue was 48.48M (YoY +10.56%), missed estimates; EPS was -0.45 (YoY -4600.00%), missed estimates.

Revenue / YoY

48.48M

+10.56%

EPS / YoY

-0.45

-4600.00%

Report date

Mar 10, 2026

ULBI Earnings Call Summary for Q4,2025

Revenue Growth: Q4 2025 revenue up 10.6% YoY to $48.5M, full year 2025 revenue up 16.2% to $191.2M, driven by Battery & Energy segment.
Margin Expansion: Gross margin improved to 24.9% (up 70bps YoY), with Battery & Energy margin at 25.1% (up 170bps YoY).
2026 Priorities: Communication Systems profitability, Battery & Energy gross margin improvement, brand consolidation, and operational efficiency.
Key Opportunities: $25M baseline for Communications Systems, $6M+ annual medical order, and thin cell technology expansion.

Earnings

EPS

Revenue

Revenue & Expenses

ULBI has released its 2025 Q3 earnings report, with revenue of 43.37M, reflecting a YoY change of 21.51%, and net profit of -1.25M, showing a YoY change of -546.95%. The Sankey diagram below clearly presents ULBI's revenue sources and cost distribution.

Key Indicators

Ultralife (ULBI) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Ultralife (ULBI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Ultralife (ULBI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Ultralife (ULBI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown